Dr Agarwal's Health Care has received go ahead from market regulator Securities and Exchange Board of India (SEBI) to float initial public offerings (IPO). The IPO is a combination of a fresh issue of up to Rs 300 crore and an Offer For Sale, (OFS) of up to 6.95 crore equity shares by promoters and other selling shareholders. The offer also includes a subscription for eligible employees. Those selling shares in the OFS include Arvon Investments, Claymore Investments (Mauritius), and Hyperion Investments.
Proceeds from the fresh issue to the tune of Rs 195 crore will be used for payment of debt, a portion will be used for general corporate purposes, and for unidentified inorganic acquisition. Kotak Mahindra Capital Company, Morgan Stanley India Company, Jefferies India and Motilal Oswal Investment Advisors are the book-running lead managers to the IPO.
Dr Agarwal’s Health Care offers a wide array of services including cataract, refractive, and other surgeries, consultations, diagnosis, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 6992.60 |
Max Healthcare Inst | 1107.30 |
Narayana Hrudayalay | 1775.90 |
Aster DM Healthcare | 511.70 |
Global Health | 1177.45 |
View more.. |